U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792083) titled 'Microbiological and Biochemical Profiling of Amniotic Fluid in Women With Short Cervix or Premature Rupture of Membranes' on Dec. 19, 2025.
Brief Summary: This study aims at assessing the efficacy, reliability, and clinical impact of Amniotic Fluid analysis by Nanopore DNA sequencing compared to the standard bacterial cultures in detecting intra-amniotic/inflammation in patients with short cervix or premature rupture of membranes.
Study Start Date: Dec. 23, 2025
Study Type: INTERVENTIONAL
Condition:
Short Cervix
PROM, Preterm (Pregnancy)
Intervention:
OTHER: amniotic fluid collection
Amniotic fluid by amniocentesis or by ster...